Evidence map›Paper›PMID 23645183›Full record

ReviewCurrent pain and headache reports2013

Burning mouth syndrome: a review of recent literature.

Larry Charleston

Abstract readReview
PubMed Publisher
In one paragraph

Review in Current pain and headache reports, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 35 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Larry CharlestonUCNS Certified Headache Medicine, ABPN Certified Adult Neurology, Belmont, MI, USA. cec14@me.com
College Of Certified Psychophysiologists · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Burning mouth syndrome (BMS) is a complex chronic disorder of orofacial sensation that is challenging in both diagnosis and treatment. The diagnosis of BMS is primarily one of exclusion, and recently classification of the disorder has been challenged. Although the exact pathophysiology of primary BMS is unknown, there has been a growing body of work to provide insight into the pathogenesis of the disorder over the past few years. Pharmacological treatments recently reported to have some success in BMS include anxiolytics, anticonvulsants, antidepressants, atypical antipsychotics, histamine receptor antagonist, and dopamine agonists. In addition, other therapies and treatments are being considered. This paper reports many of the most recent data related to BMS and its classification, diagnosis, impact on quality of life, pathophysiology, co-morbidities, and pharmacological and non-pharmacological treatments.

Indexed as

AnticonvulsantsAntidepressive AgentsAntipsychotic AgentsBenzodiazepinesBurning Mouth SyndromeDiagnosis, DifferentialDopamine AgonistsFemaleHistamine H2 AntagonistsHumansLow-Level Light TherapyMaleNervous System Physiological PhenomenaQuality of LifeRandomized Controlled Trials as TopicAnticonvulsantsAntidepressive AgentsAntipsychotic AgentsBenzodiazepinesDopamine AgonistsHistamine H2 Antagonists

Identifiers

PMID23645183
OpenAlexW2015059487

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.